Randy Vince

1.1k total citations
48 papers, 523 citations indexed

About

Randy Vince is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Urology. According to data from OpenAlex, Randy Vince has authored 48 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 9 papers in Urology. Recurrent topics in Randy Vince's work include Prostate Cancer Diagnosis and Treatment (22 papers), Prostate Cancer Treatment and Research (14 papers) and Global Cancer Incidence and Screening (9 papers). Randy Vince is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (22 papers), Prostate Cancer Treatment and Research (14 papers) and Global Cancer Incidence and Screening (9 papers). Randy Vince collaborates with scholars based in United States, Austria and Netherlands. Randy Vince's co-authors include Daniel E. Spratt, Riccardo Autorino, Lance J. Hampton, Nicholas A. Deebel, Jonathan E. Shoag, Adam P. Klausner, B. Mayer Grob, Brandon A. Mahal, Daniel J. George and Lorelei A. Mucci and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Randy Vince

44 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Randy Vince United States 13 297 142 59 57 56 48 523
Carol McPherson United States 9 191 0.6× 222 1.6× 53 0.9× 43 0.8× 13 0.2× 14 494
Rashid K. Sayyid Canada 13 344 1.2× 131 0.9× 54 0.9× 50 0.9× 7 0.1× 57 549
Cynthia T. Soloway United States 8 513 1.7× 161 1.1× 68 1.2× 20 0.4× 37 0.7× 8 713
Olaf Schoffer Germany 14 98 0.3× 195 1.4× 12 0.2× 104 1.8× 30 0.5× 59 709
Joanna B. Madalinska Netherlands 8 302 1.0× 250 1.8× 35 0.6× 60 1.1× 6 0.1× 9 786
Linda Drevin Sweden 12 356 1.2× 130 0.9× 46 0.8× 33 0.6× 5 0.1× 20 498
Alexander E. Sherman United States 12 67 0.2× 262 1.8× 21 0.4× 109 1.9× 28 0.5× 31 728
Charles L. Murray United States 5 182 0.6× 167 1.2× 52 0.9× 22 0.4× 11 0.2× 6 372
Santino Butler United States 14 384 1.3× 246 1.7× 10 0.2× 49 0.9× 8 0.1× 33 626
Radiša Tomić Sweden 10 353 1.2× 113 0.8× 39 0.7× 33 0.6× 12 0.2× 19 460

Countries citing papers authored by Randy Vince

Since Specialization
Citations

This map shows the geographic impact of Randy Vince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Vince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Vince more than expected).

Fields of papers citing papers by Randy Vince

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randy Vince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Vince. The network helps show where Randy Vince may publish in the future.

Co-authorship network of co-authors of Randy Vince

This figure shows the co-authorship network connecting the top 25 collaborators of Randy Vince. A scholar is included among the top collaborators of Randy Vince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randy Vince. Randy Vince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jang, Albert, Prateek Jain, Adam Calaway, et al.. (2025). Advanced urothelial carcinoma treated with enfortumab vedotin and pembrolizumab: a path to cure?. The Oncologist. 30(9).
2.
Davis, Laura, et al.. (2025). Oncologic and renal function outcomes of segmental ureterectomy vs. radical nephroureterectomy in upper tract urothelial carcinoma: A systematic review and meta-analysis. Urologic Oncology Seminars and Original Investigations. 43(9). 498–510. 1 indexed citations
3.
Dee, Edward Christopher, Kenrick Ng, Gloryanne Aidoo-Micah, et al.. (2024). Racial disparities in prostate cancer in the UK and the USA: similarities, differences and steps forwards. Nature Reviews Urology. 22(4). 223–234. 4 indexed citations
4.
Davis, Laura, et al.. (2024). A Rare Cause of Colon Perforation After Percutaneous Nephrolithotomy—A Case Report and Review of the Literature. SHILAP Revista de lepidopterología. 2024(1). 4475216–4475216. 2 indexed citations
6.
Mmonu, Nnenaya A., Yongmei Qin, Samuel R. Kaufman, et al.. (2023). Understanding the Role of Urology Practice Organization and Racial Composition in Prostate Cancer Treatment Disparities. JCO Oncology Practice. 19(5). e763–e772. 2 indexed citations
7.
Vince, Randy, Merrick Bank, Yilun Sun, et al.. (2023). Evaluation of Social Determinants of Health and Prostate Cancer Outcomes Among Black and White Patients. JAMA Network Open. 6(1). e2250416–e2250416. 46 indexed citations
8.
Lewicki, Patrick, Spyridon P. Basourakos, Randy Vince, et al.. (2022). Race and prostate cancer: genomic landscape. Nature Reviews Urology. 19(9). 547–561. 22 indexed citations
9.
Alshalalfa, Mohammed, Idalid Franco, Randy Vince, et al.. (2022). Clinicogenomic characterization of prostate cancer liver metastases. Prostate Cancer and Prostatic Diseases. 25(2). 366–369. 13 indexed citations
10.
Vince, Randy, Scott Jamieson, Brandon A. Mahal, & Willie Underwood. (2021). Examining the Racial Disparities in Prostate Cancer. Urology. 163. 107–111. 20 indexed citations
11.
Vince, Randy, Ji Qi, Jeffrey J. Tosoian, et al.. (2021). Impact of Decipher Biopsy testing on clinical outcomes in localized prostate cancer in a prospective statewide collaborative. Prostate Cancer and Prostatic Diseases. 25(4). 677–683. 19 indexed citations
12.
Tosoian, Jeffrey J., Rodney L. Dunn, Yashar S. Niknafs, et al.. (2021). Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study. European Urology Open Science. 29. 30–35. 2 indexed citations
13.
Vince, Randy, et al.. (2021). Racial disparities in prostate cancer among black men: epidemiology and outcomes. Prostate Cancer and Prostatic Diseases. 25(3). 397–402. 60 indexed citations
14.
Vince, Randy, Judith Stangl‐Kremser, Daniel Triner, et al.. (2021). 692P Characterization of the tumor immune microenvironment in early-stage clear cell renal cell carcinoma (ccRCC): Prognostic value of an M0-macrophage enriched subtype. Annals of Oncology. 32. S707–S707. 1 indexed citations
15.
Фролов, К. А., Randy Vince, Rebecca Zee, et al.. (2021). A preliminary study of bilateral color mapping of pig bladder vasculature demonstrates potential for acute hemi-ischemic events. Translational Andrology and Urology. 10(6). 2410–2417. 2 indexed citations
16.
Vince, Randy, Judith Stangl‐Kremser, C. T. Russell, et al.. (2021). Molecular Characterization of Clear Cell Renal Cell Carcinoma Reveals Prognostic Significance of Epithelial-mesenchymal Transition Gene Expression Signature. European Urology Oncology. 5(1). 92–99. 8 indexed citations
17.
Downs, Tracy M., Ekene Enemchukwu, Cheryl T. Lee, et al.. (2020). Supporting Black voices in urology. Nature Reviews Urology. 18(1). 7–17. 3 indexed citations
18.
Tracey, Andrew, Uzoma A. Anele, Randy Vince, et al.. (2019). Bladder attack: transient bladder ischemia leads to a reversible decrease in detrusor compliance. Translational Andrology and Urology. 8(6). 703–711. 2 indexed citations
20.
Deebel, Nicholas A., et al.. (2017). Prostate Cancer in Transgender Women: Incidence, Etiopathogenesis, and Management Challenges. Urology. 110. 166–171. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026